These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 409590)

  • 41. Gentamicin-resistant Pseudomonas aeruginosa: Mayo Clinic Experience, 1970-1976.
    Keys TF; Washington JA
    Mayo Clin Proc; 1977 Dec; 52(12):797-801. PubMed ID: 413012
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Comparative in vitro activity of 5 beta-lactams (cefoperazone, cefsulodin, ceftazidime, azthreonam, N-formimidoyl-thienamycin) on 90 strains of Pseudomonas aeruginosa with various levels of resistance to ticarcillin].
    Le Noc P; Robert J; Le Noc D
    Pathol Biol (Paris); 1984 May; 32(5):404-7. PubMed ID: 6429611
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Susceptibility of nonfermentative gram-negative bacilli to tobramycin.
    Uwaydah M; Taqi-Eddin AR
    J Infect Dis; 1976 Aug; 134 Suppl():S28-32. PubMed ID: 823278
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Inactivation of aminoglycoside-penicillin combinations after subconjunctival injection.
    Ellis PP; Rendi MA
    Can J Ophthalmol; 1981 Apr; 16(2):79-83. PubMed ID: 7306873
    [TBL] [Abstract][Full Text] [Related]  

  • 45. In vitro activity of polyunsaturated fatty acids on Pseudomonas aeruginosa: relationship to lipid peroxidation.
    Giamarellos-Bourboulis EJ; Grecka P; Dionyssiou-Asteriou A; Giamarellou H
    Prostaglandins Leukot Essent Fatty Acids; 1998 Apr; 58(4):283-7. PubMed ID: 9654401
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Tobramycin and ticarcillin therapy for exacerbations of pulmonary disease in patients with cystic fibrosis.
    Parry MF; Neu HC
    J Infect Dis; 1976 Aug; 134 Suppl():S194-7. PubMed ID: 823276
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Structures and biological activities of tobramycin-ticarcillin adducts.
    Huh K; Wilton JH; Nix DE; Schentag JJ
    J Pharm Sci; 1994 Jun; 83(6):763-7. PubMed ID: 9120803
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Synergism between maggot excretions and antibiotics.
    Cazander G; Pawiroredjo JS; Vandenbroucke-Grauls CM; Schreurs MW; Jukema GN
    Wound Repair Regen; 2010; 18(6):637-42. PubMed ID: 20946137
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Comparative activity of beta-lactam antibiotics against 'intrinsically' ticarcillin-resistant strains of Pseudomonas aeruginosa.
    Bert F; Bruneau B; Lambert-Zechovsky N; Branger C
    Chemotherapy; 1994; 40(3):183-7. PubMed ID: 8205936
    [TBL] [Abstract][Full Text] [Related]  

  • 50. In vitro susceptibility of pseudomonas to four beta-lactamantibiotics (ampicillin, cephalothin, carbenicillin, piperacillin), to four aminoglycosides (kanamycin, amikacin, gentamicin, tobramycin) and to colimycin.
    Hoogkamp-Korstanje JA; Westerdaal NA
    Chemotherapy; 1979; 25(1):48-53. PubMed ID: 253637
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Sensitivity to carbenicillin and ticarcillin, and the beta-lactamases of Pseudomonas aeruginosa in the UK in 1978-79.
    King JD; Farmer T; Reading C; Sutherland R
    J Clin Pathol; 1980 Mar; 33(3):297-301. PubMed ID: 6769973
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The in vitro activity of gentamicin, tobramycin and netilmicin against 500 clinical isolates of bacteria. A comparative study using three different test media.
    Digranes A; Dibb WL; Benonisen E; Ostervold B
    Acta Pathol Microbiol Immunol Scand B; 1983 Apr; 91(2):135-9. PubMed ID: 6408889
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Global and effective synergism of amikacin, gentamicin or tobramycin when combined with carbenicillin against Pseudomonas aeruginosa.
    Ximenes J; Hirai CK; Takenaka IM
    J Int Med Res; 1979; 7(5):375-8. PubMed ID: 115732
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Laboratory findings of tobramycin and their relation to clinical response.
    McAllister TA; Tait SC
    J Infect Dis; 1976 Aug; 134 Suppl():S20-7. PubMed ID: 823277
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Alterations in Pseudomonas aeruginosa exoproducts by sub-MICs of some antibiotics.
    Hostacká A; Majtán V
    Folia Microbiol (Praha); 1993; 38(4):349-52. PubMed ID: 8112696
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Transduction of amikacin, gentamicin and tobramycin resistance in Pseudomonas aeruginosa.
    Knothe H; Krcméry V; Mitsuhashi S
    Zentralbl Bakteriol A; 1980 Mar; 246(3):373-8. PubMed ID: 6775445
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Susceptibility of Pseudomonas aeruginosa to aminoglycosides: effect of free calcium and magnesium].
    Christe M; Vaudaux P; Waldvogel FA
    Schweiz Med Wochenschr; 1982 Feb; 112(7):234-41. PubMed ID: 6803358
    [TBL] [Abstract][Full Text] [Related]  

  • 58. In vitro efficacy of Bay k 4999, a new ureido-penicillin, in combination with aminoglycosides against Pseudomonas aeruginosa, Escherichia coli, Klebsiella pneumoniae and Proteus strains.
    Daschner FD; Steffens A; Langmaack H
    Chemotherapy; 1979; 25(5):282-5. PubMed ID: 113178
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [In vitro effects of the combination of carbenicillin with gentamicin or tobramycin with respect to Pseudomonas aeruginosa].
    Turgeon PL; Croteau L
    Union Med Can; 1977 May; 106(5):682-5. PubMed ID: 405784
    [No Abstract]   [Full Text] [Related]  

  • 60. Pseudomonas aeruginosa and Acinetobacter calcoaceticus: in vitro susceptibility of 150 clinical isolates to five beta-lactam antibiotics and tobramycin.
    Dibb WL; Asphaug Kjellevold V; Digranes A
    Chemotherapy; 1983; 29(5):332-6. PubMed ID: 6311491
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.